Muscarinic acetylcholine receptors can act as a two sided coin by acting as tumor promoters or as therapeutic targets in breast cancer
We have demonstrated that muscarinic acetylcholine receptors (mAChR) are involved in breast
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
We have demonstrated that muscarinic acetylcholine receptors (mAChR) are involved in breast
The medical management of erectile dysfunction(ED) has evolved greatly over the
Limited information is available comparing the efficacy and safety of Short-Acting β2-agonists (SABAs) versus long-acting β2-agonists (LABAs) for maintenance therapy in Chronic Obstructive Pulmonary Disease (COPD
scope of this study is to convey the act of listening, the fundamental feature of affective communication, and to analyze it through Turkish proverbs and idioms. To do so, listening ... primarily focused on as a…
regulatory pathway for Biosimilars in the United States through the Biologics Competition and Innovation Act of 2009 (BPCI Act), critics have questioned inclusion of exclusivity periods in addition to existing…
ensure participant safety and research integrity. In the UK, the Safeguarding Vulnerable Groups Act (2006) further protects vulnerable individuals by regulating those who work with them. The paper emphasizes
Background: The TNNI3 gene, responsible for encoding the inhibitory subunit of the
newly proposed Direct Tax Code 2025, which is compared against the existing Income Tax Act, 1961. This evaluative comparison seeks to outline key discrepancies between the two frameworks, assess
therapy (ART), daily regimens pose challenges such as stigma, nonadherence, and treatment failure. Long-acting injectable (LAI) ART with Cabotegravir/Rilpivirine (CAB/RPV) offers an alternative, but its real-world
Isolated External Iliac Artery (EIA) aneurysms are exceptionally rare vascular anomalies, often
advent of long-acting antiretroviral therapies (LA-ARTs) has revolutionized HIV/AIDS management by addressing adherence challenges associated with daily medication regimens. LA-ARTs offer sustained drug levels, reducing…
For authors and organisers
Find the right journal for your paper and submit your manuscript.